标题
Genomics and Drug Response
作者
关键词
-
出版物
NEW ENGLAND JOURNAL OF MEDICINE
Volume 364, Issue 12, Pages 1144-1153
出版商
New England Journal of Medicine (NEJM/MMS)
发表日期
2011-03-24
DOI
10.1056/nejmra1010600
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Carbamazepine-Induced Toxic Effects and HLA-B*1502 Screening in Taiwan
- (2011) Pei Chen et al. NEW ENGLAND JOURNAL OF MEDICINE
- HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
- (2011) Mark McCormack et al. NEW ENGLAND JOURNAL OF MEDICINE
- Adjuvant therapy for postmenopausal women with endocrine-sensitive breast cancer
- (2010) Rachel A. Freedman et al. BREAST
- Adjuvant aromatase inhibitor therapy: Outcomes and safety
- (2010) Wolfgang Janni et al. CANCER TREATMENT REVIEWS
- Assessing the Clinical Utility of Diagnostics Used in Drug Therapy
- (2010) J Woodcock CLINICAL PHARMACOLOGY & THERAPEUTICS
- Reduced-Function CYP2C19 Genotype and Risk of Adverse Clinical Outcomes Among Patients Treated With Clopidogrel Predominantly for PCI
- (2010) Jessica L. Mega et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Clopidogrel and the Reduced-Function CYP2C19 Genetic Variant
- (2010) Valentin Fuster et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Genome-Wide Associations and Functional Genomic Studies of Musculoskeletal Adverse Events in Women Receiving Aromatase Inhibitors
- (2010) James N. Ingle et al. JOURNAL OF CLINICAL ONCOLOGY
- The Long and Winding Road to Warfarin Pharmacogenetic Testing**Editorials published in the Journal of the American College of Cardiologyreflect the views of the authors and do not necessarily represent the views of JACCor the American College of Cardiology.
- (2010) Geoffrey S. Ginsburg et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Warfarin Genotyping Reduces Hospitalization Rates
- (2010) Robert S. Epstein et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- ACCF/AHA Clopidogrel Clinical Alert: Approaches to the FDA “Boxed Warning”
- (2010) David R. Holmes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Effect of CYP2C19 and ABCB1 single nucleotide polymorphisms on outcomes of treatment with ticagrelor versus clopidogrel for acute coronary syndromes: a genetic substudy of the PLATO trial
- (2010) Lars Wallentin et al. LANCET
- The human genome at ten
- (2010) NATURE
- Multiple personal genomes await
- (2010) J. Craig Venter NATURE
- Has the revolution arrived?
- (2010) Francis Collins NATURE
- Ten Years On — The Human Genome and Medicine
- (2010) Harold Varmus NEW ENGLAND JOURNAL OF MEDICINE
- Genomewide Association Studies and Assessment of the Risk of Disease
- (2010) Teri A. Manolio NEW ENGLAND JOURNAL OF MEDICINE
- Genomic Medicine — An Updated Primer
- (2010) W. Gregory Feero et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects ofCYP2C19Genotype on Outcomes of Clopidogrel Treatment
- (2010) Guillaume Paré et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of Mutated, Activated BRAF in Metastatic Melanoma
- (2010) Keith T. Flaherty et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pharmacogenetics of coumarinic oral anticoagulants
- (2010) Vangelis G Manolopoulos et al. PHARMACOGENOMICS
- VKORC1,CYP2C9andCYP4F2genetic-based algorithm for warfarin dosing: an Italian retrospective study
- (2010) Carlo-Federico Zambon et al. PHARMACOGENOMICS
- A genome-wide association study of acenocoumarol maintenance dosage
- (2009) Martina Teichert et al. HUMAN MOLECULAR GENETICS
- Association of Cytochrome P450 2C19 Genotype With the Antiplatelet Effect and Clinical Efficacy of Clopidogrel Therapy
- (2009) Alan R. Shuldiner JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CYP4F2 Is a Vitamin K1 Oxidase: An Explanation for Altered Warfarin Dose in Carriers of the V433M Variant
- (2009) M. G. McDonald et al. MOLECULAR PHARMACOLOGY
- Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance
- (2009) Dongliang Ge et al. NATURE
- HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
- (2009) Ann K Daly et al. NATURE GENETICS
- Interferon-alfa, interferon-λ and hepatitis C
- (2009) Thomas R O'Brien NATURE GENETICS
- IL28B is associated with response to chronic hepatitis C interferon-α and ribavirin therapy
- (2009) Vijayaprakash Suppiah et al. NATURE GENETICS
- Genome-wide association of IL28B with response to pegylated interferon-α and ribavirin therapy for chronic hepatitis C
- (2009) Yasuhito Tanaka et al. NATURE GENETICS
- Estimation of the Warfarin Dose with Clinical and Pharmacogenetic Data
- (2009) NEW ENGLAND JOURNAL OF MEDICINE
- Interleukin-17 and Type 17 Helper T Cells
- (2009) Pierre Miossec et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Genome-Wide Association Study Confirms VKORC1, CYP2C9, and CYP4F2 as Principal Genetic Determinants of Warfarin Dose
- (2009) Fumihiko Takeuchi et al. PLoS Genetics
- Analysis of IL-10, IL-4 and TNF-α polymorphisms in drug-induced liver injury (DILI) and its outcome
- (2008) Ketevan Pachkoria et al. JOURNAL OF HEPATOLOGY
- HLA-B*5701 Screening for Hypersensitivity to Abacavir
- (2008) Simon Mallal et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cytochrome P-450 Polymorphisms and Response to Clopidogrel
- (2008) Jessica L. Mega et al. NEW ENGLAND JOURNAL OF MEDICINE
- Carbamazepine,HLA-B*1502and risk of Stevens–Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
- (2008) P Brent Ferrell et al. PHARMACOGENOMICS
- 2007 Focused Update of the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention
- (2007) Spencer B. King et al. CIRCULATION
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started